RE:RE:RE:RE:RE:RE:RE:The IPF and Chronic Cough study is now on the back burner. What we saw was Mackie smacking the c-rap out of Algernon Pharmaceuticals with their analysis of the COVID-19 Phase II Topline data readout. If the CEO crawls back to them with another PP that would be yet another astonishingly unfortunate thing to witness. I mean Mackie sank Algernon's battleship! Warranted...maybe?! You lie with dogs you catch fleas, but maybe that was the underplay for the overplay anyway? Meaning, the inside job was someone (KM)/others plugged in, knew that a hit piece was coming and made a killing on the downfall of the stock. What's certain is that the reputation of the company has been severely damaged. Primarily due to the inability to get to data readouts in a reasonable time frame with one excuse after the other. You can't expect the market to fall in love with your endless stories but don't deliver the end of the story as stated. People got other shiit to do as well with their money other than throwing it down a wishing well. Missing data readouts one after the other is a death knell to your corporate reputation. The market is buying into a timeline to data. The CEO has stated a bunch of times how "EVERYBODY WANTS IN AT PHASE 2". Hindsight being 20/20, does anyone here wish they had sat out on the IPF and Chronic Cough story?
BB